Integral Health Asset Management LLC Makes New Investment in Centene Corporation $CNC

Integral Health Asset Management LLC acquired a new position in Centene Corporation (NYSE:CNC) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 400,000 shares of the company’s stock, valued at approximately $14,272,000. Integral Health Asset Management LLC owned approximately 0.08% of Centene as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. WPG Advisers LLC grew its stake in shares of Centene by 44.5% in the 3rd quarter. WPG Advisers LLC now owns 915 shares of the company’s stock worth $33,000 after purchasing an additional 282 shares during the last quarter. Versant Capital Management Inc lifted its stake in Centene by 11.6% during the third quarter. Versant Capital Management Inc now owns 3,421 shares of the company’s stock valued at $122,000 after purchasing an additional 355 shares during the last quarter. Snowden Capital Advisors LLC boosted its holdings in Centene by 8.0% during the second quarter. Snowden Capital Advisors LLC now owns 5,073 shares of the company’s stock worth $275,000 after buying an additional 374 shares in the last quarter. MAI Capital Management grew its position in Centene by 6.3% in the third quarter. MAI Capital Management now owns 6,545 shares of the company’s stock worth $234,000 after buying an additional 388 shares during the last quarter. Finally, Financial Network Wealth Advisors LLC lifted its position in shares of Centene by 54.9% during the 3rd quarter. Financial Network Wealth Advisors LLC now owns 1,100 shares of the company’s stock valued at $39,000 after acquiring an additional 390 shares during the last quarter. 93.63% of the stock is owned by institutional investors and hedge funds.

Centene Stock Performance

Shares of CNC opened at $34.47 on Friday. The firm has a market cap of $16.95 billion, a price-to-earnings ratio of -2.53, a price-to-earnings-growth ratio of 0.77 and a beta of 0.48. The company’s fifty day moving average is $42.81 and its 200-day moving average is $38.33. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.87. Centene Corporation has a 12 month low of $25.08 and a 12 month high of $66.03.

Centene (NYSE:CNC) last released its quarterly earnings data on Friday, February 6th. The company reported ($1.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.22) by $0.03. The business had revenue of $49.73 billion during the quarter, compared to analyst estimates of $48.41 billion. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. Centene’s quarterly revenue was up 21.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.80 EPS. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. Equities analysts expect that Centene Corporation will post 6.86 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

CNC has been the subject of a number of recent analyst reports. Sanford C. Bernstein reiterated an “outperform” rating and issued a $59.00 price target on shares of Centene in a research report on Tuesday, January 6th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Centene from $32.00 to $39.00 and gave the stock a “hold” rating in a research note on Tuesday, February 10th. Wall Street Zen downgraded shares of Centene from a “buy” rating to a “hold” rating in a research note on Sunday, February 15th. Weiss Ratings reiterated a “sell (d)” rating on shares of Centene in a report on Wednesday, January 21st. Finally, Wells Fargo & Company set a $44.00 price target on shares of Centene and gave the stock an “equal weight” rating in a research report on Wednesday, February 18th. Three analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $42.06.

Centene Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.